Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
29.88
+0.70 (2.40%)
At close: Jul 14, 2026, 4:00 PM EDT
30.00
+0.12 (0.40%)
After-hours: Jul 14, 2026, 7:00 PM EDT
Maze Therapeutics Revenue
Maze Therapeutics had revenue of $20.00M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $20.00M, down -88.06% year-over-year.
Revenue (ttm)
$20.00M
Revenue Growth
-88.06%
P/S Ratio
82.69
Revenue / Employee
$141,844
Employees
141
Market Cap
1.65B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 167.50M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMAZE News
- 4 weeks ago - Maze Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Maze Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Maze Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Maze Therapeutics Slides: Investor presentation - Filings
- 6 weeks ago - Maze Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Maze Therapeutics reports Q1 EPS (45c), consensus (63c) - TheFly
- 2 months ago - Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 2 months ago - Maze Therapeutics Earnings release: Q1 2026 - Filings